First Lilly Gateway Labs site outside US, China to be completed in Incheon’s Songdo by July 2027
Samsung Biologics has teamed up with Eli Lilly to set up an open innovation hub for emerging biotechnology companies in Korea, marking the first time for Eli Lilly to establish such a site outside the United States and China.
According to Samsung Biologics on Tuesday, the two companies agreed to build a Lilly Gateway Labs site within the Korean c
Continue Reading on The Korea Herald
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.